Canada
Genomics England Limited (GEL), with the consent of participants from the NHS is creating a “lasting legacy for Patients” in the form of its flagship project, the sequencing of 100k complete genomes by 2017. The project will focus on patients with rare diseases & their families, as well as patients with common cancers. 10 specialist centres from across the UK have been selected to carry out the recruitment and referral of consenting patients.
Click here to read the full article.